Doctors Ben and Sean Behnam built an alternative to one-size-fits-all solutions with their new company, Happy Head.
Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone could become a game-changing treatment for male-pattern hair loss. The ...
At the same time, the market has become crowded and sometimes confusing. Large, high-volume centres sit alongside surgeon-led ...
As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...
Clascoterone 5%, a topical anti-androgen drug indicated for male pattern hair loss, demonstrated significant hair regrowth ...
Trying to fix a thinning mane? It’s a hairy situation. More than 80% of men and nearly half of women in the US will face some form of hair loss in their lifetime, and thousands of companies are ...
A new experimental scalp treatment called clascoterone has shown strong results in helping reduce male-pattern hair loss (also known as androgenetic alopecia, or AGA). Experts call the results ...
ISTANBUL, Türkiye, December 15, 2025 (EZ Newswire) -- Turkey has strengthened its position as one of the world’s leading destinations for medical tourism, particularly in hair transplantation.
India Today on MSN
New hair-loss drug draws attention after trial success: Doctors break down its real impact
A new experimental hair-loss treatment has sent Cosmo Pharmaceuticals' stock soaring. But doctors say the drug is promising, ...
The topical medication, called Clascoterone, could represent the first truly novel drug for male pattern baldness seen in about 30 years. Reading time 2 minutes Are you a man worried about losing your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results